ImCheck Therapeutics Appoints Dr. Loui Madakamutil as CSO
ImCheck Therapeutics Appoints Dr. Loui Madakamutil, Noted Expert in Immunology and Autoimmune Diseases, as Chief…
Month: April 2021
While ElsaLys continues to work on the filing of marketing approval in Europe and the U.S. for inolimomab, the company confirms the renew of its cohort ATU in France and compassionate use programs submissions in several other countries
While ElsaLys continues to work on the filing of marketing approval in Europe and the…
Chr. Hansen Holding A/S Interim report Q2 2020/21
Continued strong organic growth momentum leads to upwards narrowing of full-year organic growth guidance …
New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder
Study concludes that psilocybin findings should be explored further in larger studies London, UK, April…
Roche’s Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA)
More than twice as many babies (61% vs. 29%) were able to sit without support…
Soleno Therapeutics Participates in Prader-Willi Syndrome (PWS) DCCR Town Hall
REDWOOD CITY, Calif., April 14, 2021 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
ImmuCell Closes $4,250,000 Equity Financing
PORTLAND, Maine, April 14, 2021 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”),…
Biogen to Present Trial Design of Aducanumab EMBARK Re-Dosing Study in Poster Session at 2021 Virtual AAN Annual Meeting on April 17-22, 2021
CAMBRIDGE, Mass., April 14, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) today announced it will…
Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors
MALVERN, Pa., April 14, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical…
Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
Virtual KOL Event is scheduled for Tuesday, April 27th @ 10:30 AM ET AUSTIN, Texas,…
CytomX Therapeutics Announces New Employment Inducement Grants
SOUTH SAN FRANCISCO, Calif., April 14, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a…
Harrow Health Announces Offering of $25 Million Senior Notes Due 2026 and “BB” Rating from Egan-Jones
NASHVILLE, Tenn., April 14, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused…
Primo Nutraceuticals Inc. Corporate Update
VANCOUVER, British Columbia, April 14, 2021 (GLOBE NEWSWIRE) — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC:…
Harrow Health Announces Preliminary First Quarter 2021 Financial Results
NASHVILLE, Tenn., April 14, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused…
Emerging Markets Report: A Moment for the Mushroom
Core One Labs Looking to Compete in Psylocibin with a Proprietary Offering at a Fraction…
Innovation Pharma’s Broad Spectrum Antiviral Drug Candidate Brilacidin Highlighted in Biodefense and Infectious Diseases COVID-19 Presentation
WAKEFIELD, Mass., April 14, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical…
Cosmos Holdings Launches Proprietary King Eros and Queen Venus Supplements for Enhanced Libido
Sky Premium Life King Eros and Queen Venus Supplements Sky Premium Life King Eros and…
Alimera Sciences Receives $20 Million From Ocumension Therapeutics
Alimera grants exclusive license to Ocumension for a $10 million upfront payment and up to…
Medicenna to Present at the Bloom Burton & Co. Healthcare Investor Conference
TORONTO and HOUSTON, April 14, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the…